The Parliamentary Health and Social Care committee has released a report on Brexit: medicines, medical devices and substances of human origin.
Fiona Loud, Policy Director at Kidney Care UK provided evidence to the Health and Social Care Committee enquiry and is quoted within the report. She said: “There continues to be a lot of uncertainty around what will happen once the UK leaves the EU. This uncertainty will undoubtedly cause stress for people with kidney disease who rely on dialysis equipment, research and the continued development of medicines and treatments from across Europe.
It is vital that these arrangements are preserved once the UK leaves the EU and that the safe movement of organs and blood are retained, as well as reciprocal healthcare arrangements which are so important for the 29,000 people on dialysis in the UK in order to travel in Europe. We are calling for a clear commitment from the government to protect patients post-Brexit because the needs of people with long-term conditions will continue to cross borders.”
Concern for dialysis patients who wish to tr…
UK still to reach no-deal healthcare agreements with multiple EU countries, leaving kidney patients in limbo
Blind runner takes on Great North Run for Ki…
Nicola Stevens is running to raise awareness of kidney disease after being diagnosed herself in 2011